• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性和慢性β受体阻滞剂对正常男性二氧化碳敏感性的影响。

Effect of acute and chronic beta-blockade on carbon dioxide sensitivity in normal man.

作者信息

Hutchinson P F, Harrison R N

出版信息

Thorax. 1980 Nov;35(11):869-72. doi: 10.1136/thx.35.11.869.

DOI:10.1136/thx.35.11.869
PMID:6784264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC471401/
Abstract

The effect of beta-adrenoceptor antagonists on the respiratory response to carbon dioxide rebreathing was studied in eight normal subjects. Propranolol, atenolol, metoprolol, and placebo were given in random, double-blind fashion. Subjects were studied before each treatment period, after one dose, and after eight days of treatment with each drug. A rebreathing method was used to produce progressive hypercapnia and the respiratory response was assessed by measuring minute ventilation and maximum rate of change of inspiratory mouth pressure. Beta-blockade was assessed by the reduction in heart rate during steady state exercise on a cycle ergometer. There was no change in the respiratory response to carbon dioxide after a single dose or eight days treatment of any drug. All three active drugs produced a significant reduction in exercise heart rate. The forced expiratory volume in one second was not altered by any of the drugs.

摘要

在八名正常受试者中研究了β-肾上腺素能受体拮抗剂对二氧化碳再呼吸时呼吸反应的影响。普萘洛尔、阿替洛尔、美托洛尔和安慰剂以随机、双盲方式给药。在每个治疗期之前、一剂后以及每种药物治疗八天后对受试者进行研究。采用再呼吸方法产生渐进性高碳酸血症,并通过测量分钟通气量和吸气口压的最大变化率来评估呼吸反应。通过在自行车测力计上进行稳态运动时心率的降低来评估β受体阻滞情况。任何一种药物单次给药或治疗八天后,对二氧化碳的呼吸反应均无变化。所有三种活性药物均使运动心率显著降低。一秒用力呼气量未因任何一种药物而改变。

相似文献

1
Effect of acute and chronic beta-blockade on carbon dioxide sensitivity in normal man.急性和慢性β受体阻滞剂对正常男性二氧化碳敏感性的影响。
Thorax. 1980 Nov;35(11):869-72. doi: 10.1136/thx.35.11.869.
2
Ventilatory response to hypercapnia in normal subjects after propranolol, metoprolol and oxprenolol.普萘洛尔、美托洛尔和氧烯洛尔作用于正常受试者后对高碳酸血症的通气反应。
Respiration. 1980;39(3):139-43. doi: 10.1159/000194208.
3
Failure of propranolol and metoprolol to alter ventilatory responses to carbon dioxide and exercise.普萘洛尔和美托洛尔未能改变对二氧化碳和运动的通气反应。
Br J Clin Pharmacol. 1980 May;9(5):493-8. doi: 10.1111/j.1365-2125.1980.tb05845.x.
4
Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.阿替洛尔、美托洛尔和普萘洛尔对正常受试者异丙肾上腺素诱发的震颤和心动过速的影响。
Clin Pharmacol Ther. 1981 Apr;29(4):425-33. doi: 10.1038/clpt.1981.59.
5
Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.阿替洛尔、美托洛尔和普萘洛尔对麻醉猫β-肾上腺素能受体的阻断作用。
Eur J Pharmacol. 1979 May 1;55(3):263-8. doi: 10.1016/0014-2999(79)90193-6.
6
Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide.β-肾上腺素能阻滞剂对二氧化碳通气反应的无效性。
Clin Pharmacol Ther. 1982 Sep;32(3):289-94. doi: 10.1038/clpt.1982.162.
7
Relative activities of atenolol and metoprolol on the cardiovascular system of man.阿替洛尔和美托洛尔对人体心血管系统的相对活性。
Eur J Clin Pharmacol. 1981;20(1):9-15. doi: 10.1007/BF00554660.
8
Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.新型β-肾上腺素能受体拮抗剂比索洛尔对人体β-肾上腺素能受体选择性的评估。
Br J Clin Pharmacol. 1984 Sep;18(3):343-7. doi: 10.1111/j.1365-2125.1984.tb02474.x.
9
Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.β-肾上腺素能受体阻滞剂与中枢神经系统相关主观症状:美托洛尔缓释片/佐剂、阿替洛尔和普萘洛尔长效制剂在健康受试者中的随机、双盲、安慰剂对照比较
J Clin Pharmacol. 1990 Feb;30(S2):S103-7. doi: 10.1002/j.1552-4604.1990.tb03506.x.
10
The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.单次给药后β-肾上腺素能受体拮抗剂对华法林药代动力学和药效学的影响。
Br J Clin Pharmacol. 1984 May;17(5):553-7. doi: 10.1111/j.1365-2125.1984.tb02389.x.

引用本文的文献

1
Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise.糖尿病患者对低氧、高碳酸血症和运动的呼吸反应。
Thorax. 1984 Jul;39(7):529-34. doi: 10.1136/thx.39.7.529.

本文引用的文献

1
EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.β-肾上腺素能阻滞剂普萘洛尔对哮喘患者的影响。
Lancet. 1964 Nov 21;2(7369):1101-2. doi: 10.1016/s0140-6736(64)92617-0.
2
A clinical method for assessing the ventilatory response to carbon dioxide.一种评估对二氧化碳通气反应的临床方法。
Australas Ann Med. 1967 Feb;16(1):20-32. doi: 10.1111/imj.1967.16.1.20.
3
Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects.β-肾上腺素能受体阻滞剂对正常人和哮喘患者气道传导率及肺容积的影响。
Br Med J. 1969 Jul 19;3(5663):143-5. doi: 10.1136/bmj.3.5663.143.
4
Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.给药途径对β-肾上腺素能阻滞与血浆普萘洛尔水平之间关系的影响。
Clin Pharmacol Ther. 1972 Mar-Apr;13(2):181-5. doi: 10.1002/cpt1972132181.
5
Effects of beta-adrenergic blockade and stimulation on normal human airways.β-肾上腺素能阻滞和刺激对正常人气道的影响。
J Appl Physiol. 1973 Nov;35(5):613-9. doi: 10.1152/jappl.1973.35.5.613.
6
The rate of isometric inspiratory pressure development as a measure of responsiveness to carbon dioxide in man.以等长吸气压力发展速率作为衡量人体对二氧化碳反应性的指标。
Clin Sci Mol Med. 1975 Jul;49(1):57-68. doi: 10.1042/cs0490057.
7
Tissue distribution of metoprolol-(3-h) in the mouse and the rat.美托洛尔 -(3 - H)在小鼠和大鼠体内的组织分布
Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):116-24. doi: 10.1111/j.1600-0773.1975.tb03328.x.
8
Carbon dioxide rebreathing and mouth occlusion pressure measurements.二氧化碳重复呼吸和口腔闭合压测量。
J R Coll Physicians Lond. 1977 Oct;12(1):87-95.
9
Reduced respiratory responses to carbon dioxide after propranolol: a central action.普萘洛尔后对二氧化碳的呼吸反应降低:一种中枢作用。
Br Med J. 1976 Nov 20;2(6046):1229-31. doi: 10.1136/bmj.2.6046.1229.
10
Effects of muliple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung disease.
Scand J Respir Dis. 1976;57(4):190-6.